RT @PDBrownOnc@twitter.com
Landmark trial RTOG1205 reirradiation recurrent #GBM
•Small GTVs 18 cc
•80% 1st relapse
•Significant PFS benefit, important clinically if options limited
•No OS benefit possibly due to salvage RT on Bev alone arm
•Link:
http://ascopubs.org/doi/full/10.1200/JCO.22.00164
🐦🔗: https://twitter.com/PDBrownOnc/status/1610311774062116867